The TANGO Study
The TANGO Study for Post-Transplant Glomerular Diseases
The TANGO study aims to create a large international network of centers to study glomerular disease (GN) recurrence after renal transplantation.
Trial for people with
The TANGO study will enroll adult (≥18 years) patients with a biopsy-proven primary Glomerular Disease (IgA nephropathy, Membranous glomerulonephritis, Focal and segmental glomerulosclerosis, Atypical hemolytic uremic syndrome, Membranoproliferative glomerulonephritis old classification type I-III, Complement- or IgG-positive membranoproliferative, glomerulonephritis, Dense-deposit disease, C3 glomerulonephritis) as the designated cause of their end-stage kidney disease who underwent a kidney transplant starting in January 2005 or later.
The purpose of the TANGO study is to create a large international network of centers to study kidney disease that recur after renal transplantation. Since many of these kidney diseases that recur are rare, it is crucial that we involve many centers around the world to collect individualized information that will help to understand the disease and identify new treatments.
What is involved for the Patient?
Your clinical information and samples (blood and urine) will be analyzed anonymously. This will help better understand individual diseases and potentially identify new potential treatments. You may choose to be contacted in the future as discoveries are made and potential novel treatments become available for your condition.
About the drug or intervention
Learn more at http://tangoxstudy.com
- Study CoordinatorThe TANGO Study Team
- Study Coordinator Emailcontact@tangoxstudy.com
- Study Coordinator Phone617-525-8008